296 related articles for article (PubMed ID: 16438876)
1. [Evaluation of transcatheter arterial chemoembolization in the prevention of postoperative recurrence in 1630 patients with hepatocellular carcinoma].
Cheng HY; Xu W; Xu AM; Chen D; Yang YF; Jia YC
Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):626-8. PubMed ID: 16438876
[TBL] [Abstract][Full Text] [Related]
2. [Appraisal of postoperative transcatheter arterial chemoembolization (TACE) for prevention and treatment of hepatocellular carcinoma recurrence].
Lin Z; Ren Z; Xia J
Zhonghua Zhong Liu Za Zhi; 2000 Jul; 22(4):315-7. PubMed ID: 11778559
[TBL] [Abstract][Full Text] [Related]
3. [Exploration of indication of prophylactic transcatheter arterial chemoembolization on postoperative recurrence of hepatocellular carcinoma].
Wang QX; Yan JJ; Zhou FG; Shen J; Yan YQ
Zhonghua Wai Ke Za Zhi; 2009 May; 47(10):748-51. PubMed ID: 19615209
[TBL] [Abstract][Full Text] [Related]
4. Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness.
Sergio A; Cristofori C; Cardin R; Pivetta G; Ragazzi R; Baldan A; Girardi L; Cillo U; Burra P; Giacomin A; Farinati F
Am J Gastroenterol; 2008 Apr; 103(4):914-21. PubMed ID: 18177453
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous treatment of hepatocellular carcinoma in patients with transjugular intrahepatic portosystemic shunts.
Tesdal IK; Wikström M; Flechtenmacher C; Filser T; Dueber C
Cardiovasc Intervent Radiol; 2006; 29(5):778-84. PubMed ID: 16779690
[TBL] [Abstract][Full Text] [Related]
6. [Transcatheter hepatic arterial chemoembolization on recurrent hepatocellular carcinoma after resection].
Ge NL; Ren ZG; Ye SL; Lin ZY; Xia JL; Gan YH; Li LX; Shen YF; Tang ZY
Zhonghua Zhong Liu Za Zhi; 2005 Jun; 27(6):380-2. PubMed ID: 16117905
[TBL] [Abstract][Full Text] [Related]
7. Role of mesohepatectomy with or without transcatheter arterial chemoembolization for large centrally located hepatocellular carcinoma.
Chen XP; Hu DY; Zhang ZW; Zhang BX; Chen YF; Zhang WG; Qiu FZ
Dig Surg; 2007; 24(3):208-13. PubMed ID: 17522469
[TBL] [Abstract][Full Text] [Related]
8. Re-evaluation of lipiodolized transarterial chemoembolization therapy for intrahepatic recurrence of hepatocellular carcinoma after curative liver resection.
Eguchi S; Matsumoto S; Hamasaki K; Takatsuki M; Hidaka M; Tajima Y; Sakamoto I; Kanematsu T
J Hepatobiliary Pancreat Surg; 2008; 15(6):627-33. PubMed ID: 18987934
[TBL] [Abstract][Full Text] [Related]
9. [Role of post-operative transcatheter arterial chemoembolization in hepatocellular carcinoma with different pathological characteristics].
Xi T; Yan ZL; Wang K; Li J; Xia Y; Shen F; Wu MC
Zhonghua Wai Ke Za Zhi; 2007 May; 45(9):587-90. PubMed ID: 17688789
[TBL] [Abstract][Full Text] [Related]
10. Influence of transcatheter arterial chemoembolization on the prognosis after hepatectomy for hepatocellular carcinoma in patients with severe liver dysfunction.
Kaibori M; Tanigawa N; Matsui Y; Saito T; Uchida Y; Ishizaki M; Tanaka H; Kamiyama Y
Anticancer Res; 2006; 26(5B):3685-92. PubMed ID: 17094386
[TBL] [Abstract][Full Text] [Related]
11. Effect of preoperative transcatheter arterial chemoembolization on apoptosis of hepatocellular carcinoma cells.
Xiao E; Li D; Shen S; Zhou S; Tan L; Wang Y; Luo J; Wu Y; Tan C; Liu H; Zhu H
Chin Med J (Engl); 2003 Feb; 116(2):203-7. PubMed ID: 12775230
[TBL] [Abstract][Full Text] [Related]
12. [High intensity focused ultrasound therapy combined with transcatheter arterial chemoembolization for advanced hepatocellular carcinoma].
Jin CB; Wu F; Wang ZB; Chen WZ; Zhu H
Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):401-3. PubMed ID: 12921577
[TBL] [Abstract][Full Text] [Related]
13. Ionic versus nonionic contrast media solvents used with an epirubicin-based agent for transarterial chemoembolization of hepatocellular carcinoma.
Tzeng WS; Wu RH; Chang SC; Chou CK; Lin CY; Chen JJ; Yang SC; Lin CH
J Vasc Interv Radiol; 2008 Mar; 19(3):342-50. PubMed ID: 18295692
[TBL] [Abstract][Full Text] [Related]
14. [Effect of postoperative transcatheter arterial chemoembolization on hepatocellular carcinoma patients with residual tumor].
Ren ZG; Lin ZY; Xia JL; Zhang BH; Ye SL; Chen SY; Gan YH; Wu XF; Chen Y; Ge NL; Wu ZQ; Ma ZC; Zhou XD; Fan J; Qin LX; Ye QH; Sun HC; Zhou J; Tang ZY
Zhonghua Zhong Liu Za Zhi; 2004 Feb; 26(2):116-8. PubMed ID: 15059334
[TBL] [Abstract][Full Text] [Related]
15. [Effect of postoperative adjuvant transarterial chemoembolization upon early recurrence after radical resection of hepatocellular carcinoma].
Chen XH; Zhang BH; Yin X; Qiu SJ; Fan J; Ren ZG; Xia JL; Wang YH; Ye SL; Gan YH
Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(12):826-9. PubMed ID: 20450622
[TBL] [Abstract][Full Text] [Related]
16. [Long-term result of combination of transcatheter arterial chemoembolization and percutaneous ethanol injection for treatment of hepatocellular carcinoma].
Chen XM; Luo PF; Lin HH; Zhou ZJ; Shao PJ; Fu L; Li WK
Ai Zheng; 2004 Jul; 23(7):829-32. PubMed ID: 15248922
[TBL] [Abstract][Full Text] [Related]
17. Indication of chemoembolization therapy without gelatin sponge for hepatocellular carcinoma.
Suzuki M; Suzuki H; Yamamoto T; Mamada Y; Mizuno H; Tominaga T; Suga M; Suemori S; Kato Y; Sato A; Yamanouchi E; Sakuyama K; Maeyama S; Shinagawa T; Okabe K
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-110-S6-115. PubMed ID: 9151925
[TBL] [Abstract][Full Text] [Related]
18. Previous chemoembolization response after transcatheter arterial chemoembolization (TACE) can predict the anti-tumor effect of subsequent TACE with miriplatin in patients with recurrent hepatocellular carcinoma.
Imai N; Ikeda K; Seko Y; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Saitoh S; Suzuki F; Suzuki Y; Arase Y; Kumada H
Oncology; 2011; 80(3-4):188-94. PubMed ID: 21709428
[TBL] [Abstract][Full Text] [Related]
19. Biliary phenotype of hepatocellular carcinoma after preoperative transcatheter arterial chemoembolization.
Nishihara Y; Aishima S; Kuroda Y; Iguchi T; Taguchi K; Asayama Y; Taketomi A; Kinukawa N; Honda H; Tsuneyoshi M
J Gastroenterol Hepatol; 2008 Dec; 23(12):1860-8. PubMed ID: 18823434
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy with transarterial chemoembolization and interferon-alpha compared with transarterial chemoembolization alone for hepatitis B virus related unresectable hepatocellular carcinoma.
Li M; Lu C; Cheng J; Zhang J; Cao C; Xu J; Xu J; Pan H; Zhong B; Tucker S; Wang D
J Gastroenterol Hepatol; 2009 Aug; 24(8):1437-44. PubMed ID: 19486255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
